These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 14103651)

  • 21. [CHANGES IN THE QUANTITY OF MATURE NEUTROPHIL "DRUMSKICKS" IN CHRONIC MYELOSIS IN WOMEN].
    RIABOV SI; KATSEVMAN AE
    Probl Gematol Pereliv Krovi; 1964 Jun; 9():15-8. PubMed ID: 14216849
    [No Abstract]   [Full Text] [Related]  

  • 22. [Casuistics on myleran treatment in chronic myelocytic leukemia].
    KOSENOW W
    Arch Kinderheilkd; 1956; 153(3):251-4. PubMed ID: 13355417
    [No Abstract]   [Full Text] [Related]  

  • 23. [Immediate results of treatment of chronic myelosis with myleran].
    SOLOVEI DIa; IAVORKOVSKII LI
    Sov Med; 1959 Nov; 23():58-62. PubMed ID: 13832703
    [No Abstract]   [Full Text] [Related]  

  • 24. A CYTOGENETIC STUDY ON THE THERAPEUTIC EFFECT OF MYLERAN IN A CASE OF CHRONIC MYELOID LEUKAEMIA.
    JUNG F; BLATNIK D; JUNG M
    Acta Med Iugosl; 1963; 17():321-35. PubMed ID: 14182420
    [No Abstract]   [Full Text] [Related]  

  • 25. Chronic myeloid leukaemia: cytogenetic studies before and after splenic irradiation.
    TOUGH IM; COURT BROWN WM; BAIKIE AG; BUCKTONKE ; HARNDEN DG; JACOBS PA; WILLIAMS JA
    Lancet; 1962 Jul; 2(7247):115-20. PubMed ID: 13922129
    [No Abstract]   [Full Text] [Related]  

  • 26. [Melanoderma appearing after a long administration of Myleran in 3 patients with chronic myeloid leukemia].
    MATHE C; DEBRAY J; BRULE G; LAUFER J
    Nouv Rev Fr Hematol; 1961; 1():624-5. PubMed ID: 14471071
    [No Abstract]   [Full Text] [Related]  

  • 27. [STUDY OF THE ENZYMES INVOLVED IN THE SYNTHESIS AND DISINTEGRATION OF GLYCOGEN IN DONOR THROMBOCYTES AND IN THROMBOCYTES OF PATIENTS WITH CHRONIC MYELOSIS AND POLYCYTHEMIA].
    EGOROVA VA; BLINOVA AI; SEITS IF
    Biull Eksp Biol Med; 1965 Mar; 59():58-61. PubMed ID: 14310867
    [No Abstract]   [Full Text] [Related]  

  • 28. Myleran in the treatment of chronic myelogenous leukemia.
    UMEGAKI Y; WATANABE I
    Acta Unio Int Contra Cancrum; 1959; 15(Suppl 1)():294. PubMed ID: 13840347
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment of chronic granulocytic leukemia with 1, 4-dimethanesulfonyloxybutane (myleran).
    SCHILLING RF; MEYER OO
    N Engl J Med; 1956 May; 254(21):986-9. PubMed ID: 13322198
    [No Abstract]   [Full Text] [Related]  

  • 30. Myeloproliferative disorders. Classification and diagnostic features with special emphasis on chronic myelogenous leukemia and agnogenic myeloid metaplasia.
    Hyun BH; Gulati GL; Ashton JK
    Clin Lab Med; 1990 Dec; 10(4):825-38. PubMed ID: 2272176
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Splenectomy in chronic myeloid leukemia and myelofibrosis with myeloid metaplasia.
    Mesa RA; Elliott MA; Tefferi A
    Blood Rev; 2000 Sep; 14(3):121-9. PubMed ID: 10986148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Bone marrow aplasia in therapy of chronic myelosis with myleran].
    ANTIC M; RADOJEVIC B
    Srp Arh Celok Lek; 1961 Jun; 89():731-5. PubMed ID: 13861763
    [No Abstract]   [Full Text] [Related]  

  • 33. [Colcemid and myleran in the treatment of chronic myelosis].
    WILDHACK R
    Dtsch Med Wochenschr; 1957 Mar; 82(10):342-6. PubMed ID: 13427505
    [No Abstract]   [Full Text] [Related]  

  • 34. [Chronic myelogenous leukemia and myelofibrosis occurring in the same family at about the same time].
    Yasuda K; Okumura S; Mori A; Inoue H; Naitou K
    Nihon Naika Gakkai Zasshi; 2002 Sep; 91(9):2771-3. PubMed ID: 12373905
    [No Abstract]   [Full Text] [Related]  

  • 35. [Pregnancy in a woman with chronic myelocytic leukemia treated with myleran].
    PEST R
    Pol Tyg Lek; 1960 Apr; 15():521-2. PubMed ID: 14432150
    [No Abstract]   [Full Text] [Related]  

  • 36. Myleran therapy in malignant neoplastic disease; use of 1,4-dimethanesulfonyloxbutane with emphasis on chronic granulocytic leukemia.
    HYMAN GA; GELLHORN A
    J Am Med Assoc; 1956 Jun; 161(9):844-9. PubMed ID: 13319018
    [No Abstract]   [Full Text] [Related]  

  • 37. Evaluation of the comparative effectiveness of Myleran and 6-MP in the management of patients with chronic myelocytic leukemia.
    SHULLENBERGER CC
    Cancer Chemother Rep; 1962 Feb; 16():203-7. PubMed ID: 13912386
    [No Abstract]   [Full Text] [Related]  

  • 38. The chronic myeloproliferative disorders: an historical perspective.
    Steensma DP
    Curr Hematol Rep; 2003 May; 2(3):221-30. PubMed ID: 12901343
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myleran treatment of chronic granulocytic leukemia.
    FRELICK RW
    Del State Med J; 1956 Oct; 28(10):255-64. PubMed ID: 13365310
    [No Abstract]   [Full Text] [Related]  

  • 40. USE OF TESTOSTERONE AND BUSULFAN IN THE TREATMENT OF MYELOFIBROSIS WITH MYELOID METAPLASIA.
    SILVER RT; JENKINS DE; ENGLE RL
    Blood; 1964 Mar; 23():341-53. PubMed ID: 14130445
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.